Literature DB >> 12598549

Unification of the "burst" and "linear" theories of periodontal disease progression: a multilevel manifestation of the same phenomenon.

M S Gilthorpe1, A T Zamzuri, G S Griffiths, I H Maddick, K A Eaton, N W Johnson.   

Abstract

Previously, burst and linear theories for periodontal disease progression were proposed based on different but limited statistical methods of analysis. Multilevel modeling provides a new approach, yielding a more comprehensive model. Random coefficient models were used to analyze longitudinal periodontal data consisting of repeated measures (level 1), sites (level 2), teeth (level 3), and subjects (level 4). Large negative and highly significant correlations between random linear and quadratic time coefficients indicated that subjects and teeth with greater-than-average linear change experienced decelerated variation. Conversely, subjects and teeth with less-than-average linear change experienced accelerated variation. Change therefore exhibited a dynamic regression to the mean at the tooth and subject levels. Since no equilibrium was attained throughout the study, changes were cyclical. When considered as a multilevel system, the "linear" and "burst" theories of periodontal disease progression are a manifestation of the same phenomenon: Some sites improve while others progress, in a cyclical manner.

Mesh:

Year:  2003        PMID: 12598549     DOI: 10.1177/154405910308200310

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  19 in total

1.  Cigarette smoking and periodontal disease among 32-year-olds: a prospective study of a representative birth cohort.

Authors:  W Murray Thomson; Jonathan M Broadbent; David Welch; James D Beck; Richie Poulton
Journal:  J Clin Periodontol       Date:  2007-10       Impact factor: 8.728

2.  Dealing with hierarchical data in periodontal research.

Authors:  Hans-Peter Müller
Journal:  Clin Oral Investig       Date:  2008-12-16       Impact factor: 3.573

3.  Partitioning degrees of freedom in hierarchical and other richly-parameterized models.

Authors:  Yue Cui; James S Hodges; Xiaoxiao Kong; Bradley P Carlin
Journal:  Technometrics       Date:  2010-02-01

4.  A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers.

Authors:  Ian Needleman; Jean Suvan; Mark S Gilthorpe; Richard Tucker; Geoff St George; William Giannobile; Maurizio Tonetti; Martin Jarvis
Journal:  J Clin Periodontol       Date:  2007-02-23       Impact factor: 8.728

5.  Induction of IL-10-producing CD4+ T-cells in chronic periodontitis.

Authors:  R Kobayashi; T Kono; B A Bolerjack; Y Fukuyama; R S Gilbert; K Fujihashi; J Ruby; K Kataoka; M Wada; M Yamamoto; K Fujihashi
Journal:  J Dent Res       Date:  2011-02-18       Impact factor: 6.116

Review 6.  Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Authors:  Corneliu Sima; Ana Viniegra; Michael Glogauer
Journal:  J Leukoc Biol       Date:  2018-11-19       Impact factor: 4.962

7.  Multilevel modeling of gingival bleeding on probing in young adult carriers of non-JP2-like strains of Aggregatibacter actinomycetemcomitans.

Authors:  Hans-Peter Müller
Journal:  Clin Oral Investig       Date:  2008-08-13       Impact factor: 3.573

Review 8.  The use of rodent models to investigate host-bacteria interactions related to periodontal diseases.

Authors:  Dana T Graves; Daniel Fine; Yen-Tung A Teng; Thomas E Van Dyke; George Hajishengallis
Journal:  J Clin Periodontol       Date:  2008-02       Impact factor: 8.728

9.  Cannabis smoking and periodontal disease among young adults.

Authors:  W Murray Thomson; Richie Poulton; Jonathan M Broadbent; Terrie E Moffitt; Avshalom Caspi; James D Beck; David Welch; Robert J Hancox
Journal:  JAMA       Date:  2008-02-06       Impact factor: 56.272

10.  Review of osteoimmunology and the host response in endodontic and periodontal lesions.

Authors:  Dana T Graves; Thomas Oates; Gustavo P Garlet
Journal:  J Oral Microbiol       Date:  2011-01-17       Impact factor: 5.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.